BIO CEO: Presenter Resource Center

  • Recommend
  • Tweet
  • Print
  • Email

Deadlines   |   Presenter Toolkit   |   Registration Instructions   |   Media Toolkit

About Company Presentations

The 17th Annual BIO CEO & Investor Conference features presentations by over 130 leading biotechnology and pharmaceutical companies, as well as a number of nonprofit and venture philanthropy organizations. Last year we not only scheduled over 1200+ Partnering Meetings, but also opened additional company presentation slots as we were sold out weeks before the conference!

Presenting Companies are hand-selected for the event, and consist of a selection of mid- to large-cap established public companies from around the globe, who typically have a clinical stage program centered around therapeutics, molecular diagnostics, or a platform technology, as well as an upcoming clinical, regulatory, or corporate catalyst. This year will once again feature 13-minute private company presentations, for established companies past their Series B financing round and that have raised >$25M. The typical audience for a company presentation features public and private equity investors, as well as industry analysts, investment bankers and senior biotechnology executives.

If you've been invited to present, confirm your presentation early to guarantee your spot! We are also accepting applications, submit one today!



Upcoming Deadlines

  • Registration: Opens in Late October
  • Early-Rate Registration Discount: December 12, 2014
  • One-on-One Partnering™:  Early December 2014
  • One-on-One PartneringTM Scheduling Begins: Late January 2015
  • The Waldorf Astoria Room Discount: Please book your Waldorf Astoria reservation using the discount group code BIO for our special $285/night + tax rate.
  • Investor Kits to Arrive at BIO's Headquarters by: TBA
  • Webcasting Available: TBA
  • Questions about Webcasting: Email bio@veracast.com

 

Presenter Toolkit

More information coming soon. Check back for the following items:

  • Presenter Checklist:
    Important deadlines regarding your presentation and Partnering.
  • Presentation Details & Guidelines:
    Logistics to ensure your presentation goes smoothly.
  • Investor Kits:
    All Investor Kits should be shipped to BIO's headquarters and not the Waldorf Astoria. Please email jfernandez@bio.org to notify us that you will be sending materials and you will then receive a shipping form. All Investor Kits must be received at BIO's headquarters in early February. We cannot guarantee their display if shipped directly to The Waldorf or sent to BIO without notification.
  • BIO CEO & Investor Conference Presentation Title Slide:
    Download the BIO CEO PowerPoint template to use for your presentation: coming soon.
     

Registration Instructions

Presenters can choose from two Registration Packages for the event.

The Group Package includes registration for three people. This package is available for both private companies and public companies.

The Individual Registration option allows you to register your Presenter and pay your company's presentation fee. You will find the breakdown of fees for both private companies and public companies on this page.

ALL presenters must be issued codes in order to begin Registration. Those who have confirmed their presentation should email their package selection and number of attendees to jfernandez@bio.org.

Other registration questions? Find registration options for investors and other companies and organizations here.
 

Media Toolkit

More information coming soon. Check back for the following items:

  • Press Release Template: Coming soon
  • Interview Opportunities: For more information, please email Abigail at ahirsch@bio.org or Daniel at dseaton@bio.org
  • Registered Media List - Late January 2015

 

Media Coverage 

The BIO CEO & Investor Conference is a must-attend event for reporters covering the business of biotech and remains a widely-publicized event in the media. Numerous top tier and trade outlets typically cover the event, including BioWorld, Bloomberg, CNBC, Forbes, In Vivo, Merger Market, Nature, Pink Sheet, Scrip, The Deal, Thomson Reuters and the Wall Street Journal